ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.

Ola Rizq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.